Generics in the Antivirals Market to 2018 – Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth – Sacramento Bee

In 2009, after patent expiry of Valtrex (valacyclovir), its generic equivalents were launched. In 2010, Famvir (famciclovir), potent antiviral from Novartis lost its patent exclusivity and its generic equivalents are currently available.